The positive results of the in vivo immunohistochemical analysis of CD31 and histopathological changes in the glioma tissue verified the antiangiogenesis and antitumor effects of MSN-DOX-PDA-NGR, respectively. This evidence concerns the gene PECAM1 and central nervous system cancer.